In vitronifedipine release from poly(lactic acid)/chitosan nanoparticles loaded with nifedipine

2016 ◽  
Vol 133 (16) ◽  
pp. n/a-n/a ◽  
Author(s):  
Nguyen Thuy Chinh ◽  
Nguyen Thi Thu Trang ◽  
Nguyen Vu Giang ◽  
Dinh Thi Mai Thanh ◽  
To Thi Xuan Hang ◽  
...  
2018 ◽  
Vol 59 (S1) ◽  
pp. E350-E360 ◽  
Author(s):  
Nibal Hijazi ◽  
Nicolas Le Moigne ◽  
Elisabeth Rodier ◽  
Martial Sauceau ◽  
Thierry Vincent ◽  
...  

2010 ◽  
Vol 80 (3) ◽  
pp. 833-838 ◽  
Author(s):  
Ashish Dev ◽  
N.S. Binulal ◽  
A. Anitha ◽  
S.V. Nair ◽  
T. Furuike ◽  
...  

2020 ◽  
Vol 35 (2) ◽  
pp. 77-91
Author(s):  
Fahad Pervaiz ◽  
Madiha Saleem ◽  
Akram Ashames ◽  
Sahrish Rehmani ◽  
Rubina Qaiser ◽  
...  

This study was designed to improve the permeability of two drugs (finasteride and minoxidil) through the skin. Finasteride-loaded poly(lactic acid- co-glycolic acid) and minoxidil-loaded chitosan nanoparticles were prepared by nanoprecipitation and ionic gelation method, respectively, and subsequently incorporated into semisolid Carbopol 940 gel. These fabricated nanoparticles were characterized for their pharmaceutical and chemical behavior. Nanoparticles were found a nearly spherical shape in the scanning electron microscopic studies and exhibited particle size in a range of 211–1012 nm. Finasteride- and minoxidil-loaded nanoparticles were optimized for relatively higher entrapment efficiency of 98% and 95%, respectively, by using the optimal concentration of polymers and stabilizers. All formulations were clear with smooth homogeneous texture and having pH values compatible with that of skin. This nanoparticulate system suspended in gel prolonged the release of drugs for up to 24 h and enhanced the drug permeability through the skin and retention of drug-loaded nanoparticles within the hair follicular routes. Therefore, these nanoparticles incorporated in the gel were found as a promising candidate for topical application in the treatment of alopecia by reducing the dosing frequency and adverse effects and as an effective strategy for improving the patient compliance toward therapy.


2011 ◽  
Vol 131 (5) ◽  
pp. 395-400 ◽  
Author(s):  
Toru Oi ◽  
Katsuyoshi Shinyama ◽  
Shigetaka Fujita

2014 ◽  
Vol 134 (4) ◽  
pp. 237-242
Author(s):  
Naru Matsugasaki ◽  
Katsuyoshi Shinyama ◽  
Shigetaka Fujita

2020 ◽  
Vol 62 (6) ◽  
pp. 732-743
Author(s):  
Chi-Hui Tsou ◽  
Jipeng Guo ◽  
Ji-Ang Lei ◽  
Manuel Reyes De Guzman ◽  
Maw-Cherng Suen
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document